Palifermin and Chlorhexidine Mouthwashes in Prevention of Chemotherapy-Induced Mucositis in Children with Acute Lymphocytic Leukemia: a Randomized Controlled Trial.

PubWeight™: 0.75^‹?›

🔗 View Article (PMID 27942550)

Published in J Dent (Shiraz) on December 01, 2016

Authors

Narges Gholizadeh¹, Masoumeh Mehdipoor², Hasan Sajadi³, Mahdieh-Sadat Moosavi⁴

Author Affiliations

1: Dept. of Oral Medicine, School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran, Dept. of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.
2: Dept. of Oral Medicine, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
3: School of Dentistry, Tabriz University of Medical Sciences, Tabriz, Iran.
4: Dept. of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.

Articles cited by this ↗

The pathobiology of mucositis. Nat Rev Cancer (2004) 2.99

Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer (2007) 2.95

Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol (1998) 1.70

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer (2012) 1.17

Clinical effectiveness of palifermin in prevention and treatment of oral mucositis in children with acute lymphoblastic leukaemia: a case-control study. Int J Oral Sci (2013) 1.04

Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis. Core Evid (2010) 1.01

Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemother Res Pract (2012) 0.95

Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2012) 0.93

Psychometric properties of the Oral Mucositis Daily Questionnaire for child self-report and importance of mucositis in children treated with chemotherapy. Support Care Cancer (2011) 0.85

Oral mucositis in children suffering from acute lymphoblastic leukaemia. Contemp Oncol (Pozn) (2012) 0.84

Melphalan 180 mg/m2 can be safely administered as conditioning regimen before an autologous stem cell transplantation (ASCT) in multiple myeloma patients with creatinine clearance 60 mL/min/1.73 m2 or lower with use of palifermin for cytoprotection: results of a phase I trial. Biol Blood Marrow Transplant (2012) 0.83

Caphosol, a therapeutic option in case of cancer therapy-induced oral mucositis in children? : Results from a prospective multicenter double blind randomized controlled trial. Support Care Cancer (2013) 0.83

Clinical applications of palifermin: amelioration of oral mucositis and other potential indications. J Cell Mol Med (2013) 0.81

Palifermin in the management of mucositis in hematological malignancies: current evidences and future perspectives. Cardiovasc Hematol Agents Med Chem (2009) 0.81

Oral health in children with leukemia. Indian J Palliat Care (2012) 0.80